Personal stories

Scientists are better understanding the neuropsychiatric changes that strike up to 97% of patients diagnosed with this degenerative brain disease. Here’s what to know about these often distressing symptoms, and why Johnson & Johnson is working on a solution.

Artificial intelligence is revolutionizing healthcare—from improving surgical training and procedures to equipping healthcare providers with insights and personalizing care for patients around the world. See how the company is harnessing its extraordinary power.

Supported by Johnson & Johnson, the Gratitude Performances series celebrates nurses and highlights the therapeutic benefits of music

Drawing on his fascination with airplane technology, Thorsten Siess, Ph.D., came up with an idea that became the Impella heart pump. Now, 26 years since it entered the market, this groundbreaking device has helped more than 450,000 patients recover from heart injuries.

The first-of-its-kind targeted oral peptide therapy for moderate to severe plaque psoriasis has been chosen for the annual list, which recognizes innovations for their originality, ambition and impact.

Check out this infographic breakdown of the company’s third-quarter performance, with highlights from its Innovative Medicine and MedTech businesses.

Built to expand OR capacity, maintain procedural momentum and elevate performance, OTTAVA™ is opening new possibilities in surgery. Neda Cvijetic, Global Head of Robotics & Digital R&D, MedTech at Johnson & Johnson, explains what surgeons need to know.

A new type of medication is tackling a problem that has long frustrated drug developers: how to deliver peptide therapies orally and hit their target more precisely.

Johnson & Johnson’s Leonardo Diaz, M.D., addresses common misconceptions about schizophrenia, the critical importance of preventing relapse and why there’s so much optimism about treatments.

Transforming cancer patients’ own cells into a targeted treatment is a complex and nuanced process. Jessica Torfs, director of Global CAR-T Supply Chain at Johnson & Johnson, explains what it takes to deliver this cutting-edge personalized therapy.